In HER2-positive cancers, increased mean on PostcontrastT1 at SSF 2 was associated with a fivefold upregulation of MLKL. This implies that a high degree of early enhancement representing tumor angiogenesis could be associated with the increased proliferative activity and large size of HER2-positive cancer [45]. The gene discussed is ERBB2; the disease is neoplasm.